Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione in ovarian cancer a double-edged sword

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Ferroptosis in epithelial ovarian cancer:

Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential Cell Death Discovery Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target PMC Glutathione in Ovarian Cancer: A Double Edged Sword Ferroptosis: a double edged sword mediating immune tolerance of cancer Cell Death & Disease

SKU: 20731405028 · From iglepidom.org

4.9
USD24.61 USD69.61

Pay in 4 interest-free payments of $6.15 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

These transporter might play essential roles in the sequestration of oxidized glutathione in vacuoles in situation of extreme oxidative stress (Queval et al., 2011) as described below

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Ferroptosis in epithelial ovarian cancer:

While menadione (vitamin K3) is a created version of vitamin K, phylloquinone (vitamin K1) and menaquinones (vitamin K2, MK-n) are found naturally in food (57)

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Ferroptosis in epithelial ovarian cancer:

10.1001/archinte.134.3.534

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Ferroptosis in epithelial ovarian cancer:

Metabolite profiling of reduced thiol-containing metabolites was carried out in the presence of NEM

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Ferroptosis in epithelial ovarian cancer:
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products